Trials / Completed
CompletedNCT00929539
Safety and Efficacy Study of JTT-130 in Obese Type 2 Diabetic Patients
A Phase II, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy, Safety and Tolerability of JTT-130 in Treatment-naïve, Metformin Only or Metformin Plus Sulfonylurea-treated Obese Type 2 Diabetic Patients
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 496 (actual)
- Sponsor
- Akros Pharma Inc. · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the effect of JTT-130 on diabetes as well as the safety and tolerability of JTT-130 in obese Type 2 diabetic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JTT-130 | Tablets |
| DRUG | JTT-130 Placebo | Tablets |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2010-05-01
- Completion
- 2010-07-01
- First posted
- 2009-06-29
- Last updated
- 2013-02-04
Locations
62 sites across 5 countries: United States, Czechia, Hungary, Netherlands, Russia
Source: ClinicalTrials.gov record NCT00929539. Inclusion in this directory is not an endorsement.